Altria suffers Juul troubles in first half of 2022 at ‘pivotal point’ in the industry

Altria is pessimistic about the future of Juul and its investment in the company but does not think the time has come to pull the plug just yet.

The US tobacco company does see the near future as absolutely pivotal to the make-up of tobacco alternatives in the country and has said it is up to the US Food and Drug Administration (FDA) to make the right calls on authorisations to allow products on the market.